Radical Cystectomy Increases Risks for Thromboembolic Events
Patients undergoing radical cystectomy for bladder cancer have an increased risk of thromboembolic events that may persist for months after surgery.
Patients undergoing radical cystectomy for bladder cancer have an increased risk of thromboembolic events that may persist for months after surgery.
Partial vs radical cytoreductive nephrectomy for clear cell metastatic renal cell carcinoma was associated with a 54% decreased risk for other-cause mortality.
Investigators performed a subgroup analysis of the phase 3 ARASENS trial.
Grade 2 or higher gastrointestinal toxicities after hypofractionated prostate cancer radiation therapy occurred in a significantly lower proportion of men who received a hyaluronic acid spacer compared with those who did not.
Investigators estimated prevalence based on the number of de novo and recurrent cases of metastatic prostate cancer.
Phosphodiesterase-5 inhibitor use after robotic prostate cancer surgery was associated with a 57% lower risk of death.
Percutaneous cryoablation for cT1b renal tumors is associated with a higher rate of local disease recurrence compared with partial nephrectomy, new data suggest.
Investigators examined the risk of bone fracture associated with different forms of androgen deprivation therapy.
A 4Kscore of 20% or higher is independently associated with a 1.7-fold increased risk for disease progression compared with a lower score, a study revealed.
A single-institution study revealed that 37% of patients who underwent radical cystectomy experienced at least 1 additional intervention.